When you’re looking for the right blend of combination product experience and innovative know-how for your injectable drug delivery product, combine forces with Kindeva.

Whether leveraging our proprietary platform technology or working with you to optimize your existing technology to meet patient use and product needs, our high-capacity and industry-leading aseptic capabilities guide Annex I compliance and ensure OTIF. Kindeva Drug Delivery brings together advanced facilities, renowned engineers, preclinical to full-scale manufacturing capabilities, and cutting-edge technology to achieve your goals.

Injectable delivery platforms


Our single- and dual-chamber sterile injection platforms are designed for reliability, ease of use, portability, and durability, and our patented technologies are world class. As autoinjector innovators for more than 60 years, we leverage an unrivaled breadth of knowledge to ensure every device is of the highest quality and capable of meeting FDA combination product guidelines.

Single-Chamber Autoinjector Platforms

  • Drug delivered: 0.3mL-3.0mL
  • Activation: Two-step user activation/rear safety release/automatic sharp protection
  • Status: Launched/on market

Dual-Chamber Autoinjector Platforms

  • Drug chambers: Liquid/liquid
  • Drug delivered: 0.7mL-2mL
  • Injection: Intra-muscular, drugs separated in vitro and in vivo (enhanced stability and bioavailability)
  • Activation: Two-step user activation/rear safety release
  • Status: Launched/on market

With Kindeva, you and your patients benefit from the latest in autoinjector evolution. Our newest innovations were designed to meet FDA Essential Performance Requirements with improved reliability, comply with the industry standard two-step sequence of use, and accommodate a wide variety of containers and fill volumes in a compact form factor.

With platforms (commercialized and in development) designed to provide intramuscular and subcutaneous drug delivery, use of industry standard 1mL and 2.25mL staked needle prefilled syringes, and form factor based on decades of experience, these future-forward delivery devices meet your needs for most injectable drugs.

Kindeva lab tech working with equipment
Our newest platform at a glance:
  • Two designs:
    • 0.3mL to 3mL delivery
    • <0.5mL delivery
  • Intramuscular or subcutaneous injection
  • 99.999% minimum system-level reliability
    • Meets FDA emergency use guidelines
  • Easy adjustability of key user interfaces
    • Uncap and activation forces
  • Two-step activation
    • Remove cap and press and hold down on the injection site
  • Built for expansion
    • Early designs which incorporate cartridge and dual-chamber options


With more than 50 years of aseptic fill-finish experience, Kindeva offers an unmatched range of development and manufacturing solutions for vials, cartridges, and syringes. We can fill any currently available ready-to-use formats, with easy accommodation of everything from small-scale single batches to campaign filling. Our device-agnostic approach assists you in identifying the best fit for your therapy, whether vial, cartridge, or syringe.

Delivering industry-leading automation & efficiency

We have invested in our facilities and have achieved a high degree of automation for processes that have traditionally been manual, from PUPSIT to no-touch transfers. When it comes to complex and high-cost drugs, we understand that you need every single drop of your product, and our automation allows us to increase output while reducing errors and improving efficiency. With modular filling suites, we reduce downtime and provide superior scalability.

  • 300/min line speed for cartridges and syringes; 400/min line speed for vials
  • 30-500L formulations
  • Brim fill and volumetric fill (cartridges)
  • Gas overlay, vacuum stoppering, and traditional mechanical stoppering (syringes)
  • 10-headed Optima syringe filler
  • 6-headed Syntegon cartridge filler
  • 8-headed Groninger vial filler
  • Single-use Millipore Mobius fillers
  • Annex I compliance (Bridgeton facility)

Microneedle-based drug delivery

Our microneedle drug-delivery platforms are designed for accurate dosing and reliable intradermal delivery for administration of vaccines, peptides, proteins, biologics, and small and large molecules. Whether dealing with a liquid or a solid API, our unparalleled capabilities and expertise deliver an exceptional product customized for your patients and brand.

  • Enhanced immunogenicity
  • Elimination of cold-chain storage
  • Room temperature stability
  • Greater efficacy
  • PK improvement
  • Faster onset of action
  • Better compliance & adherence
  • At-home administration
  • Eliminate needle phobia
Kindeva lab tech working with equipment

An array of solid-coated microneedles allows for simple and intuitive administration into the skin while providing consistent and accurate drug delivery.

Hollow microneedles penetrate the skin and provide a sterile fluid path of your drug into the intradermal space.

Your specialized drug delivery can be realized through our extensive capacity and unparalleled capability. For solid microneedle delivery, we can aseptically manufacture >1 million patches per year for clinical trials and have commercial manufacturing capabilities to produce ~14 million patches per year.  

Leverage expert analytical testing

Gain insight into your injectable product’s performance and quality through our analytical and testing services. We deliver unrivaled know-how, backed by over a century of analytical experience and expertise in working with regulatory bodies worldwide. Our services include drug content assays, extractable and leachable identification and characterization, drug content uniformity testing, medical device performance testing, and more.

Building the future

Our capabilities are expanding with our new, injectables fill-finish facility in Bridgeton, Missouri.
  • 155,000 square feet
  • Syringe, cartridge, and vial filling
  • 3 fully isolated high-speed fillers (Phase I)
    • Each suite operates independently
    • Utilities to support up to 7 filling suites (Phase II+)
    • 13,000 square feet of uncommitted space in the existing footprint for dedicated/custom aseptic operations (Phase II+)
  • Leading technology: isolators, ionized hydrogen peroxide, disposable formulation tank bagging system, automated/integrated PUPSIT filter testing
  • Cold storage
  • DEA Class II-V, controlled substance
  • Designed for max efficiency, compliance, and patient safety

Combine forces with Kindeva 

Kindeva’s injectable technologies provide customized drug-delivery options to suit the needs of your patients or global health security forces — always with therapeutic requirements, reliability, and ease of use at the forefront of each solution.

We can take your product from ideation to commercialization in-house with a continuity of services that enables time and cost savings while ensuring quality.

Your therapy is a force for good. Our expertise brings it into the world.  

Combine Forces With Kindeva